Syndromes of abnormal fat redistribution and metabolic complications in HIV-infected patients.
Struble
K
K
Division of Antiviral Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD, USA.
Piscitelli
S C
SC
D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008060:Lipodystrophy / Q000209:etiology / Q000517:prevention & control*; D008297:Male
D017320:HIV Protease Inhibitors